Offering mifepristone as an abortion option

Emergency Medicine

Volumn 46, Issue 2, 2001, Pages 113-119

  Pymar, Helen C ^a,b   Creinin, Mitchell D ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0004718253     PISSN: 00136654     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Glasier A, Thong KJ, Dewar M, et al. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception. N Engl J Med. 1992;327:1041-1044.
2. Frydman R, Baton C, Lelaidier C, et al. Mifepristone for induction of labour. Lancet. 1991;337:488-489.
3. Kettel LM, Murphy AA, Mortola JF, et al. Endocrine responses to long-term administration of the antiprogesterone RU 486 in patients with pelvic endometriosis. Fertil Steril. 1991;56:402-407.
4. Murphy AA, Kettel LM, Morales AJ, et al. Regression of uterine lelomyomata in response to the antiprogesterone RU 486. J Clin Endocrinol Metab. 1993;76:513-517.
5. Abortion Surveillance: Preliminary Analysis-United States, 1997. MMWR. 2000;48:1171-1174, 119. [published erratum appears in MMWR, January 14, 2000, 49(01);23].
6. Lahteemnaki P, Heikinhelmo O, Croxatto H, et al. Pharmacokinetics and metabolism of RU 486. J Steroid Biochem. 1987;27:859-863.
7. Spitz IM, Bardin CW. Mifepristone (RU 486)-a modulator of progestin and glucocorticoid action. N Engl J Med. 1993;329:404-412.
8. Spitz IM, Bardin CW, Benton L, et al. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med. 1998;338:1241-1247.
9. Winikoff B, Ellertson C, Elul B, et al. Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol. Results of a large multicenter trial in the United States. Mifepristone Clinical Trials Group. Arch Fam Med. 1998;7:360-366.
10. Ulmann A, Silvestre L, Chernama L, et al. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women. Acta Obstet Gynecol Scand. 1992;71:278-283.
11. Templeton AA. The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancy. UK Multicentre Trial. Br J Obstet Gynaecol. 1990;97:480-486.
12. McKinley C, Thong KJ, Baird DT. The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol. Hum Reprod. 1993;8:1502-1505.
13. World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial. Br J Obstet Gynaecol. 2000;107:524-530.
14. Zieman M, Fong SK, Benowitz NL, et al. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol. 1997;90:88-92.
15. Danielsson KG, Marions L, Rodriguez A, et al. Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol. 1999;93:275-280.
16. El-Refaey H, Rajasekar D, Abdalla M, et al. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med. 1995;332:983-987.
17. Ashok PW, Penney GC, Flett GM, et al. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod. 1998;13:2962-2965.
18. Schaff EA, Eisinger SH, Stadalius LS, et al. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception. 1999;59:1-6.
19. Schaff EA, Fielding SL, Eisinger SH, et al. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception. 2000;61:41-46.
20. El-Refaey H, Templeton A. Early induction of abortion by a combination of oral mifepristone and misoprostol administered by the vaginal route. Contraception. 1994;49:111-114.
21. El-Refaey H, Templeton A. Early abortion induction by a combination of mifepristone and oral misoprostol: a comparison between two dose regimens of misoprostol and their effect on blood pressure. Br J Obstet Gynaecol. 1994;101:792-796.
22. Schaff EA, Fielding SL, Westhoff C, et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion. A randomized trial. JAMA. 2000;284:1948-1953.
23. Schaff EA, Stadalius LS, Eisinger SH, et al. Vaginal misoprostol administered at home after mifepristone (RU 486) for abortion. J Fam Pract. 1997;44:353-360.
24. Jensen JT, Astley SJ, Morgan E, et al. Outcomes of suction curettage and mifepristone abortion in the United States. A prospective comparison study. Contraception. 1999;59:153-159.
25. Schaff EA, Eisinger SH, Franks P, et al. Combined methotrexate and misoprostol for early induced abortion. Arch Fam Med. 1995;4:774-779.
26. Schaff EA, Eisinger SH, Franks P, et al. Methotrexate and misoprostol for early abortion. Fam Med. 1996; 28:198-203.
27. Elul B, Ellertson C, Winikoff B, et al. Side effects of mifepristone-misoprostol abortion versus surgical abortion. Data from a trial in China, Cuba, and India. Contraception. 1999;59:107-114.